Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBI112 in Plaque Psoriasis Patients Switching from Biologics
CTR20232312Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Jul 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of picankibart in plaque psoriasis, sponsored by Innovent Biologics. Started Jul 2023; status: completed.
02
Drugs
picankibart
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20232312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232312.